Kevin Gentilini

Kevin Gentilini has a diverse work experience, primarily in regulatory affairs and quality assurance. In 2014, they completed a research internship at the Center for Immunology and Infectious Diseases (CIMI) at Inserm. In 2016, they had a quality assurance internship at Sanofi in the HAC (Highly Actives Products & Conjugates) Chemistry Site. From 2017 to 2018, they were an intern at EFS, where they worked as an alternating regulatory affairs and quality intern. In 2019, they joined Quies S.A. as a regulatory affairs executive, a position they held until 2020. Currently, they are a full-stack developer at Kabaun since May 2023.

Kevin Gentilini's education history includes multiple degrees and certifications. In 2012, they started their undergraduate studies at Université Paris-Saclay, where they pursued a Bachelor's degree in Biology-Chemistry and completed it by 2016.

After completing their undergraduate studies, Kevin continued their education at Université Paris-Saclay. In 2016, they enrolled in the Master's program "Sciences du médicament" and completed their studies in 2017.

Following their Master's degree, Kevin pursued further specialization in the field of public health. From 2017 to 2018, they attended Université Paris-Saclay's program "Master 2 Dispositifs Médicaux: Evaluation, Enregistrement et Vigilance."

In addition to their academic degrees, Kevin obtained a certification called "Mooc Gestion de projet-Parcours classique" from Centrale Lille in December 2016.